IMNM · Immunome Inc
United States · RS rating 37 · As of 2026-11-03
| Price | 20.31 USD |
|---|---|
| 1-day change | +3.7% |
| RS rating (overall / 1M / 3M / 12M) | 37 / 46 / 31 / 73 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 32 / 15 / 21 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -35.4% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +31.9% |
| Market cap (USD) | $2.6B |